Methods and compositions for recovering or improving visual...

Details Methods and compositions for recovering or improving visual... Methods and compositions for recovering or improving visual...

2006-05-03

2010-06-22

Leavitt, Maria (Department: 1633)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S093100, C424S093600, C435S320100, C435S325000

Reexamination Certificate

active

07740836

ABSTRACT:
There are disclosed methods and compositions for recovering or improving visual function in a mammal, by means of adeno-associated viral vectors suitable for gene delivery to mammalian retina.

REFERENCES:
Zeng et al., RS-1 Gene Delivery to an Adult Rs1h Knockout Mouse Model Restores ERG b-Wave with Reversal of the Electronegative Waveform of X-Linked Retinoschisis.Invest Ophthalmol Vis Sci. Sep. 2004;45(9):3279-85.
Biochemistry John Wiley and Sons, 1990, 126-128.
Palczewski et al., Ca2+-binding protein in the retina:structure, function and the etiology of human visual diseases BioEssays 22:337-350.
Blackshaw S, et al., Comprehensive analysis of photoreceptor gene expression and the identification of candidate retinal disease genes. Cell. Nov. 30, 2001;107(5):579-89.
Mayeur et al., Eight previously unidentified mutations found in the OA1 ocular albinism gene BMC Medical Genetics 2006 1-8.
Athanasopoulos T, Gene therapy vectors based on adeno-associated virus: characteristics and applications to acquired and inherited diseases (review).Int J Mol Med. Oct. 2000;6(4):363-75.
Bainbridge JW, et al., Gene therapy progress and prospects: the eye. Aug. 2006;13(16):1191-7. Epub Jul. 13, 2006.
Cortese et al., “The ocular albinism type 1 (OA1) gene controls melanosome maturation and size.” Invest Ophthalmol Vis Sci. 46(12):4358-64 (Dec. 2005).
Vetrini et al., “The microphthalmia transcription factor (Mitf) controls expression of the ocular albinism type 1 gene: link between melanin synthesis and melanosome biogenesis.” Mol Cell Biol. 24(15):6550-9 (Aug. 2004).
Incerti et al., “Oal knock-out: new insights on the pathogenesis of ocular albinism type 1 .” Hum Mol Genet. 9(19):2781-8 (Nov. 22, 2000).
Voet, Biochemistry John Wiley and Sons, 1990, pp. 126-128.
Kimchi-Sarfaty Cet al., A “silent” polymorphism in the MDR1 gene changes substrate specificity.Science. Jan. 26, 2007;315(5811):525-8.
Eck et al., 1996, Goodman & Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, p. 77-101.
Brown MD et al., 2001, Gene Delivery with synthetic (non viral) carriers, Int J Pharm, pp. 1-21.
Gorecki et al., 2001, Prospects and problems of gene therapy: an update, Expert Opin. Emerging Drugs, 6(2): 187-198.
Enrico Maria Surace et al; Amelioration of Both Functional and Morphological Abnormalities in the Retina of a Mouse Model of Ocular Albinism Following AAV-Mediated Gene Transfer; Molecular Therapy vol. xx; No. xx; Jun. 1, 2005; pp. 1-7.

Affiliated with

Also associated with

Rating

Methods and compositions for recovering or improving visual... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for recovering or improving visual..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for recovering or improving visual... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4224697